Tag: India-specific strategy

India's pharmaceutical market is poised to double from its current valuation of USD60 billion to an estimated USD120 billion by 2030, according to a report by the Organisation of Pharmaceutical Producers of India (OPPI) in collaboration with the Boston Consulting Group (BCG).(Representational image/Pixabay)
Posted in Business

India’s pharma market to double in size by 2030, hit $120 billion, claims report

The Indian healthcare sector is on a trajectory of rapid growth, with the pharmaceutical market poised to double from its current valuation of USD60 billion…

Continue Reading